LUX Lung Special Access Scheme Australia Named Patient Use (NPU)

NCT01209650 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: BIBW 2992

Sponsor

Boehringer Ingelheim